TETAVAX

Product overview

Type

Tetanus Toxoid

Commercial Name

TETAVAX

Manufacturer

Sanofi Pasteur

URL

https://www.sanofipasteur.com/en/immunization-essentials/#preventable

Responsible NRA

Agence nationale de sécurité du médicament et des produits de santé

Country

France

URL

http://www.afssaps.fr/

Prequalification

Prequalification Status

Current: No Routine Production

Effective Date

22/07/1997

Product description

Pharmaceutical Form

Liquid: ready to use

Presentation

Vial

Number of Doses

20

Diluent

Not Applicable

Route of Administration

Intramuscular

Shelf Life

36 months

Storage Temperature

2-8°C

Vaccine Vial Monitor

none

Multidose Vial Policy

Not Applicable.

Vaccine Preservative

thiomersal

Vaccine Preservative Concentration

0.01%